Dean Y Li Merck & Co., Inc. (MRK) insider trading activity

MRK Quotes by TradingView

Dean Y Li is Executive VP & President, MRL of Merck & Co., Inc.. Currently has a direct ownership of 79,592 shares of MRK, which is worth approximately $6.88 Million. The most recent transaction as insider was on Jan 27, 2025, when has been sold 32,621 shares (Common Stock) at a price of $97.94 per share, resulting in proceeds of $3,194,900. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 79.6K
72.12% 3M change
72.12% 12M change
Total Value Held $6.88 Million

Dean Y Li Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 27 2025
BUY
Grant, award, or other acquisition
$3,194,900 $97.94 p/Share
32,621 Added 29.07%
79,592 Common Stock
Feb 09 2024
SELL
Open market or private sale
$1,845,101 $125.5 p/Share
14,702 Reduced 24.12%
46,242 Common Stock
Feb 09 2024
BUY
Exercise of conversion of derivative security
$912,553 $62.07 p/Share
14,702 Added 19.44%
60,944 Common Stock
Jan 22 2024
BUY
Grant, award, or other acquisition
$3,076,516 $119.43 p/Share
25,760 Added 35.78%
46,242 Common Stock
May 01 2023
SELL
Payment of exercise price or tax liability
$60,506 $115.47 p/Share
524 Reduced 2.5%
20,471 Common Stock
May 01 2023
BUY
Exercise of conversion of derivative security
$122,629 $115.47 p/Share
1,062 Added 4.81%
20,995 Common Stock
Jan 23 2023
BUY
Grant, award, or other acquisition
$359,857 $109.88 p/Share
3,275 Added 14.11%
19,933 Common Stock
May 03 2022
SELL
Payment of exercise price or tax liability
$33,395 $87.65 p/Share
381 Reduced 2.26%
16,457 Common Stock
May 03 2022
BUY
Exercise of conversion of derivative security
$67,753 $87.65 p/Share
773 Added 4.39%
16,838 Common Stock
May 01 2022
SELL
Payment of exercise price or tax liability
$46,385 $88.69 p/Share
523 Reduced 3.15%
16,065 Common Stock
May 01 2022
BUY
Exercise of conversion of derivative security
$94,100 $88.69 p/Share
1,061 Added 6.01%
16,588 Common Stock
Feb 24 2022
BUY
Grant, award, or other acquisition
$222,221 $73.51 p/Share
3,023 Added 16.35%
15,462 Common Stock
May 04 2021
SELL
Payment of exercise price or tax liability
$18,083 $75.98 p/Share
238 Reduced 1.9%
12,309 Common Stock
May 04 2021
BUY
Exercise of conversion of derivative security
$52,730 $75.98 p/Share
694 Added 5.24%
12,547 Common Stock
May 03 2021
SELL
Payment of exercise price or tax liability
$19,146 $74.5 p/Share
257 Reduced 2.12%
11,853 Common Stock
May 03 2021
BUY
Exercise of conversion of derivative security
$55,875 $74.5 p/Share
750 Added 5.83%
12,110 Common Stock
May 01 2021
SELL
Payment of exercise price or tax liability
$26,373 $74.5 p/Share
354 Reduced 3.02%
11,360 Common Stock
May 01 2021
BUY
Exercise of conversion of derivative security
$76,735 $74.5 p/Share
1,030 Added 8.08%
11,714 Common Stock
Feb 26 2021
BUY
Grant, award, or other acquisition
$253,081 $72.62 p/Share
3,485 Added 24.65%
10,655 Common Stock

Also insider at

RXRX
RECURSION PHARMACEUTICALS, INC. Healthcare
Director
DYL

Dean Y Li

Executive VP & President, MRL
Kenilworth, NJ

Track Institutional and Insider Activities on MRK

Follow Merck & Co., Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRK shares.

Notify only if

Insider Trading

Get notified when an Merck & Co., Inc. insider buys or sells MRK shares.

Notify only if

News

Receive news related to Merck & Co., Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MRK